Pfizer gene therapy reduces bleeding rates in haemophilia A in late-stage study
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-he1-1024x576.jpg)
Pfizer the company reported that a gene therapy for haemophilia A significantly reduced the number of annual bleeding episodes in patients with the rare disease in a late-stage study and showed better outcomes than current standard treatment.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env2.jpg)
Pope Francis calls for action on climate change
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env1.jpg)
Climate change costing Africa up to 5% of GDP, UN says
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env.jpg)
A forest fire has destroyed 20% of the forests in Brazil
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-cul2.jpg)
Toronto Film Festival showcases an industry transformed by streaming
September 6, 2024
LIVE STREAM